Immunosuppressants and Skin Cancer in Transplant Patients: Focus on Rapamycin
Sylvie Euvrard, MD*, Claas Ulrich, MD, and Nicole Lefrancois, MD
Background. The responsibility of immunosuppressants for the increased risk of skin cancers in organ transplant recipients is widely recognized...